Achieving Stability For mRNA

Here, expert panelists Case and Getts share some of things researchers are exploring to keep mRNA more stable. We also cover how to advance mRNA cancer vaccine technology toward meaningful clinical outcomes, tumoral heterogeneity, routes of administration, and development of methods to assess the efficacy processes that will need to be addressed.